Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -21.76%37.76M | -15.82%163.66M | -24.80%32.17M | -24.21%36.85M | -19.85%46.38M | 6.89%48.27M | 0.19%194.42M | 215.86%42.77M | -20.90%48.62M | -3.98%57.87M |
| Cost of revenue | -10.08%136.25M | 1.41%151.53M | ||||||||
| Gross profit | -36.09%27.41M | -3.89%42.89M | ||||||||
| Operating expense | 1.80%23.52M | 24.73%23.11M | ||||||||
| Selling and administrative expenses | ---- | -4.90%25.35M | ---- | ---- | ---- | ---- | 11.59%26.66M | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | -14.30%4.32M | ---- | ---- | ---- | ---- | 19.03%5.04M | ---- | ---- | ---- |
| -General and administrative expense | ---- | -2.71%21.04M | ---- | ---- | ---- | ---- | 9.99%21.62M | ---- | ---- | ---- |
| Other operating expenses | ---- | 6.38%1.4M | ---- | ---- | ---- | ---- | -15.75%1.32M | ---- | ---- | ---- |
| Total other operating income | ---- | -33.64%3.23M | ---- | ---- | ---- | ---- | -29.73%4.87M | ---- | ---- | ---- |
| Operating profit | -141.11%-1.33M | -80.34%3.89M | -215.70%-1.5M | -137.70%-1.88M | -44.92%4.03M | -47.64%3.24M | -24.21%19.79M | -50.21%1.29M | -27.44%4.99M | 52.73%7.32M |
| Net non-operating interest income (expenses) | 29.22%1.61M | 151.31%1.25M | ||||||||
| Non-operating interest income | 23.68%611K | 26.34%2.29M | 31.59%704K | 4.14%478K | 28.01%617K | 45.72%494K | 68.21%1.82M | 72.58%535K | 53.51%459K | 74.01%482K |
| Non-operating interest expense | 19.69%152K | 19.96%679K | 114.29%315K | -21.68%112K | -10.71%125K | -6.62%127K | -2.75%566K | 162.50%147K | -7.14%143K | -30.69%140K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -45.77%-2M | -403.77%-1.37M | ||||||||
| Special income (charges) | 208.90%367K | 77.00%-337K | ||||||||
| Less:Write off | ---- | -208.90%-367K | ---- | ---- | ---- | ---- | -77.00%337K | ---- | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -107.12%-256K | -79.96%3.87M | -478.73%-2.51M | -146.42%-2.25M | -31.25%5.04M | -44.66%3.6M | -24.47%19.33M | -46.40%663K | -33.78%4.84M | 64.46%7.33M |
| Income tax | -34.77%803K | -31.54%3.94M | -7.32%608K | -72.62%368K | -22.77%1.74M | -18.58%1.23M | 6.76%5.76M | 2,724.00%656K | -25.46%1.34M | 20.01%2.25M |
| Net income | -144.78%-1.06M | -100.52%-70K | -44,657.14%-3.12M | -174.78%-2.62M | -35.01%3.3M | -52.57%2.37M | -34.56%13.57M | -99.61%7K | -36.51%3.5M | 96.74%5.08M |
| Net income continuous operations | -144.78%-1.06M | -100.52%-70K | -44,657.14%-3.12M | -174.78%-2.62M | -35.01%3.3M | -52.57%2.37M | -32.81%13.57M | -99.45%7K | -36.51%3.5M | 96.74%5.08M |
| Net income discontinuous operations | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Noncontrolling interests | -352.09%-972K | -148.43%-1.43M | 27.64%-555K | -1,562.96%-395K | -29.85%-261K | -158.58%-215K | -197.45%-574K | -232.03%-767K | -28.95%27K | -178.52%-201K |
| Net income attributable to the company | -103.37%-87K | -90.41%1.36M | -431.27%-2.56M | -163.98%-2.22M | -32.54%3.56M | -44.14%2.58M | -29.79%14.14M | -61.89%774K | -36.56%3.47M | 127.07%5.28M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -103.37%-87K | -90.41%1.36M | -431.27%-2.56M | -163.98%-2.22M | -32.54%3.56M | -44.14%2.58M | -29.79%14.14M | -61.89%774K | -36.56%3.47M | 127.07%5.28M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -103.13%-0.0003 | -90.49%0.005 | -431.03%-0.0096 | -164.34%-0.0083 | -32.65%0.0132 | -44.19%0.0096 | -29.77%0.0526 | -61.33%0.0029 | -36.76%0.0129 | 127.91%0.0196 |
| Diluted earnings per share | -103.13%-0.0003 | -90.49%0.005 | -433.33%-0.0096 | -164.34%-0.0083 | -32.65%0.0132 | -44.19%0.0096 | -29.77%0.0526 | -61.60%0.0029 | -36.76%0.0129 | 127.91%0.0196 |
| Dividend per share | 0 | -41.67%0.035 | 0.015 | 0 | -50.00%0.02 | 0 | 0.00%0.06 | 0 | 0.00%0.02 | 0.00%0.04 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.